BioSET

BioSET (Biomimetic Orthopaedic Solutions and Engineering Technologies) was a regenerative medicine company specializing in the development of orthobiologics for bone and joint repair. The company's proprietary technology platform utilized synthetic biomimetic peptides, such as B2A, designed to enhance the body's natural healing response by mimicking the action of bone morphogenetic proteins. These products were targeted at significant clinical needs in spinal fusion, orthopedic trauma, and dental reconstruction. BioSET was acquired by Ferring Pharmaceuticals in 2010, integrating its peptide-based bone repair technology into Ferring's global healthcare portfolio.